A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation is a research paper published in Integrative Biology (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
University of Wisconsin Carbone Cancer Center
Grant: P30CA014520
National Institutes of Health
Grant: R01AI13479
National Institutes of Health
Grant: R33CA225281
National Institutes of Health
Grant: R01CA186134
National Institutes of Health
Grant: R01CA185747
National Institutes of Health
Grant: R01 CA205101
National Institutes of Health
Grant: R01 CA211082
National Institutes of Health
Grant: K99ES028744
Department of Defense
Grant: W81XWH-16-1-0514
NIEHS NIH HHS
Grant: R00 ES028744
NCI NIH HHS
Grant: L30 CA111079
NIAID NIH HHS
Grant: R01 AI134749
National Institutes of Health
Grant: 1K99ES028744-01A1
Elucidating AHR signaling interplay in orofacial clefting and endocrine disruption using microplate microfluidics
National Institutes of Health
Grant: 1R33CA225281-01
Area C: Functional microscale organotypic assays to predict patient response to anti-angiogenesis therapies
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 7R01CA185747-03
Cellular level optical metabolic imaging to predict drug response in cancer
National Institutes of Health
Grant: 5R01CA211082-02
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
National Institutes of Health
Grant: 1R01DE013479-01
MYOTENDINOUS JUNCTION FORMATION IN SKELETAL MUSCLE
National Institutes of Health
Grant: 5R01CA205101-02
(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity
National Institutes of Health
Grant: 5R01CA186134-04
An automated high-throughput tissue model for screening metastatic effectors
FWCI
0.99
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
Additional file 1 of The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
Additional file 9 of The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone
Additional file 9 of The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone